CSIMarket
 
Ricebran Technologies  (RIBT)
Other Ticker:  
 
 
Price: $0.1862 $0.01 3.444%
Day's High: $0.1862 Week Perf: 24.13 %
Day's Low: $ 0.18 30 Day Perf: 43.23 %
Volume (M): 7 52 Wk High: $ 1.27
Volume (M$): $ 1 52 Wk Avg: $0.62
Open: $0.19 52 Wk Low: $0.07



 Market Capitalization (Millions $) 1
 Shares Outstanding (Millions) 7
 Employees 264
 Revenues (TTM) (Millions $) 30
 Net Income (TTM) (Millions $) -16
 Cash Flow (TTM) (Millions $) -3
 Capital Exp. (TTM) (Millions $) 1

Ricebran Technologies
We are a human food ingredient, functional food ingredient, packaged functional food and animal nutrition company focused on value-added processing and marketing of healthy, natural and nutrient dense products derived from raw rice bran, an underutilized by-product of the rice milling industry.

Using our rice bran bio-refining business model, we apply our proprietary and patented technologies and intellectual properties to convert raw rice bran into numerous high value products including stabilized rice bran (SRB), rice bran oil (RBO), defatted rice bran (DRB) and derivative products including: RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a highly nutritious, carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and our family of ProRyza products, which include derivatives including protein and protein/fiber blends.

We entered into a strategic supply partnership with the Thailand-based Narula Group of companies to add organic jasmine rice bran and organic red rice bran, as well as other organic products, to our portfolio of products.

Our target markets are organic and natural food, functional food, nutria-cosmetic and animal nutrition manufacturers, wholesalers and retailers, both domestically and internationally.

We have two reportable operating segments in 2015: (i) USA segment, which manufactures and distributes SRB (for human food ingredient and animal nutrition customers) and derivative products as well as contract manufacturing of functional food products with an emphasis on utilization of our proprietary and patented functional food ingredients; and (ii) Brazil segment, which extracts crude RBO from raw rice bran and produces DRB as a co-product. RBO is then further processed into degummed, neutralized and/or fully refined rice bran oil for sale internationally and in Brazil. DRB is sold as feed for horses, cows, swine, sheep and poultry and a number of human food and animal nutrition products. We incur corporate and other expenses not directly attributable to operating segments. These include costs related to our corporate staff, general and administrative expenses including public company expenses, intellectual property, professional fees, and other expenses. No Corporate allocations, including interest, are made to the operating segments.

The combined operations of our USA and Brazil segments encompass our bio-refining approach to processing raw rice bran into various high quality, value-added constituents and finished products. Over the past decade, we have developed and optimized our proprietary bio-refining processes to support the production of healthy, natural, hypoallergenic, gluten/soy free, and non-genetically modified ingredients for use in meats, baked goods, cereals, coatings, health foods, nutritional supplements, nutraceuticals and high-end animal nutrition and animal health products.

On January 2, 2014, we acquired H&N Distribution Inc., an Irving, Texas based company now operating as Healthy Natural, Inc. (HN) which has a formulating, blending and co-packaging facility in Irving, Texas. At that location we manufacture blended and/or packaged functional food products for the human nutrition and functional food markets.

In February 2008, through our Delaware subsidiary Nutra S.A. LLC (Nutra SA), we acquired 100% ownership of Industria Riograndens De Oleos Vegetais Ltda. (Irgovel), our rice bran oil bio-refining plant in Pelotas, Brazil. During 2011, we sold a minority interest in Nutra SA, to AF Bran Holdings-NL LLC and AF Bran Holding LLC.

We have two reportable operating segments in 2015: (i) USA segment, which manufactures and distributes SRB (for human food ingredient and animal nutrition customers) and derivative products as well as contract manufacturing of functional food products with an emphasis on utilization of our proprietary and patented functional food ingredients; and (ii) Brazil segment, which extracts crude RBO from raw rice bran and produces DRB as a co-product. RBO is then further processed into degummed, neutralized and/or fully refined rice bran oil for sale internationally and in Brazil. DRB is sold as feed for horses, cows, swine, sheep and poultry and a number of human food and animal nutrition products. We incur corporate and other expenses not directly attributable to operating segments. These include costs related to our corporate staff, general and administrative expenses including public company expenses, intellectual property, professional fees, and other expenses. No Corporate allocations, including interest, are made to the operating segments.

The combined operations of our USA and Brazil segments encompass our bio-refining approach to processing raw rice bran into various high quality, value-added constituents and finished products. Over the past decade, we have developed and optimized our proprietary bio-refining processes to support the production of healthy, natural, hypoallergenic, gluten/soy free, and non-genetically modified ingredients for use in meats, baked goods, cereals, coatings, health foods, nutritional supplements, nutraceuticals and high-end animal nutrition and animal health products.

On January 2, 2014, we acquired H&N Distribution Inc., an Irving, Texas based company now operating as Healthy Natural, Inc. (HN) which has a formulating, blending and co-packaging facility in Irving, Texas. At that location we manufacture blended and/or packaged functional food products for the human nutrition and functional food markets

In February 2008, through our Delaware subsidiary Nutra S.A. LLC (Nutra SA), we acquired 100% ownership of Industria Riograndens De Oleos Vegetais Ltda. (Irgovel), our rice bran oil bio-refining plant in Pelotas, Brazil. During 2011, we sold a minority interest in Nutra SA, to AF Bran Holdings-NL LLC and AF Bran Holding LLC.

The USA segment produces SRB inside three locations: two leased raw rice bran stabilization facilities located within supplier-owned rice mills in Arbuckle and West Sacramento, California; and one owned rice bran stabilization facility in Mermentau, Louisiana. At Dillon, Montana, the USA segment produces our process patented Stage II products including: RiSolubles, a highly nutritious, carbohydrate and lipid rich fraction of SRB; RiFiber, a fiber rich derivative of SRB; RiBalance, a complete rice bran nutritional package derived from further processing RiBalance, and our ProRyza family of products including, protein- and protein/fiber-based products. “Stage II” refers to the process patented processes run at our Dillon, Montana facility and describes products produced at that facility. The manufacturing facilities included in our USA segment have proprietary processing equipment and process patented technology for the stabilization and further processing of rice bran into finished products.

With the acquisition of HN, we formulate, blend and package finished products on a business-to-business basis for our customers at a leased facility in Irving Texas. We also lease a facility in West Sacramento, California that houses a laboratory, warehouse and facility for assembling RBT proprietary extruders for stabilizing raw rice bran. We use an owned facility in Lake Charles, Louisiana as a temporary warehouse. In 2015, approximately 84% of USA segment revenue is from sales of human nutrition products and the remainder was from sales of animal nutrition products.




   Company Address: 25420 Kuykendahl Rd., Suite B300 Tomball 77375 TX
   Company Phone Number: 675-2421   Stock Exchange / Ticker: RIBT
   RIBT is expected to report next financial results on March 15, 2024.


Customers Net Income grew by RIBT's Customers Net Profit Margin grew to

68.28 %

7.05 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
SJM   -0.55%    
ADM        0.81% 
BABB        2.47% 
BG   -3.25%    
CHSCP        0.7% 
DAR   -0.02%    
• View Complete Report
   



Ricebran Technologies

Ricebran Technologies Braces for the Future: Analyzing its Financial Decline and Potential Turnaround



Ricebran Technologies (RIBT) has witnessed a significant decline in its share performance over the last five trading days, with a year-to-date performance that is also concerning. The company's shares are currently trading below its 52-week average on the NASDAQ, raising questions about its future prospects. Recent financial results reveal a loss per share decrease compared to the previous year, a sharp drop in revenue, and a decrease in net deficit. This article aims to analyze and interpret these financial results, and discuss their potential implications for Ricebran Technologies going forward.
1. Loss per Share and Income Improvement:
For the financial period closing on September 30, 2023, Ricebran Technologies showcased a positive development by reducing its loss per share from $-0.38 to $-0.26 compared to the previous year. This indicates a potential improvement in the company's profitability. Moreover, income per share increased from $-1.54 to an undisclosed amount. These numbers suggest that Ricebran Technologies has made some positive strides towards enhancing its financial performance.

Ricebran Technologies

Ricebran Technologies Reports Astonishing -40.883% Revenue Decline in Second Quarter of 2023

In the second quarter of 2023, Ricebran Technologies reported a significant increase in shortfall per share compared to the previous year. The company's shortfall per share grew from $-0.05 to $-1.54, indicating a decline in profitability. Furthermore, the shortfall increased from $-0.31 per share from the previous financial reporting period.
Moreover, the company experienced a decline in revenue during the second quarter of 2023. Revenue faded by -40.883% to $6.02 million, compared to $10.19 million in the same period the previous year. Additionally, revenue tumbled by -35.009% sequentially, as it dropped from $9.27 million in the prior reporting period.

Ricebran Technologies

Ricebran Technologies showcases resilience amidst declining revenue, emphasizing future growth potential and employee productivity

Despite experiencing a shortfall per share of $-0.31 per share for the financial interval closing March 31, 2023, Ricebran Technologies is not a company to be overlooked. The company's revenue may have declined by -12.217 % to $9.27 million from $10.56 million in the corresponding reporting season a year prior and sequentially deteriorated by -12.688 % from $10.62 million, but there are reasons to be bullish about their future prospects.
First, the productivity of Ricebran Technologies's employees remained above the company average, even though revenue per employee fell on a trailing twelve month basis to $152,754. Second, the company has 264 employees, which means it has considerable room for growth. While it may not rank as high as some of its peers in the Consumer Non Cyclical sector, with 70 other companies achieving higher revenue per employee, the fact that Ricebran Technologies has been able to remain above its company average speaks volumes about its potential.






 

Ricebran Technologies's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com